These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 25439778)
1. C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3. Bennett DT; Reece TB; Foley LS; Sjoberg A; Meng X; Fullerton DA; Weyant MJ J Thorac Cardiovasc Surg; 2015 Jan; 149(1):369-75. PubMed ID: 25439778 [TBL] [Abstract][Full Text] [Related]
2. C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer. Al-Ghamdi S; Cachat J; Albasri A; Ahmed M; Jackson D; Zaitoun A; Guppy N; Otto WR; Alison MR; Kindle KB; Ilyas M Pancreas; 2013 Jan; 42(1):135-40. PubMed ID: 22750970 [TBL] [Abstract][Full Text] [Related]
3. Multiple pathways regulate Cten in colorectal cancer without a Tensin switch. Thorpe H; Akhlaq M; Jackson D; Al Ghamdi S; Storr S; Martin S; Ilyas M Int J Exp Pathol; 2015 Dec; 96(6):362-9. PubMed ID: 26852686 [TBL] [Abstract][Full Text] [Related]
4. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten. Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V Cancer Res; 2010 Mar; 70(6):2558-67. PubMed ID: 20215508 [TBL] [Abstract][Full Text] [Related]
5. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation. Hong SY; Shih YP; Li T; Carraway KL; Lo SH Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213 [TBL] [Abstract][Full Text] [Related]
6. C-terminal tensin-like (CTEN): a promising biomarker and target for cancer. Lo SH Int J Biochem Cell Biol; 2014 Jun; 51():150-4. PubMed ID: 24735711 [TBL] [Abstract][Full Text] [Related]
7. Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer. Wang CY; Chao TT; Tai WT; Chang FY; Su WP; Chen YL; Chen PT; Weng CY; Yuan A; Shiau CW; Yu CJ; Chen KF J Thorac Oncol; 2014 Apr; 9(4):488-96. PubMed ID: 24736071 [TBL] [Abstract][Full Text] [Related]
9. shRNA‑mediated silencing of TARBP2 inhibits NCI‑H1299 non‑small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway. Shi Y; Zuo D; Wang X; Han M; Wu Y Mol Med Rep; 2016 Oct; 14(4):3725-30. PubMed ID: 27599909 [TBL] [Abstract][Full Text] [Related]
11. Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells. Campbell TM; Main MJ; Fitzgerald EM J Cell Sci; 2013 Nov; 126(Pt 21):4939-49. PubMed ID: 23986482 [TBL] [Abstract][Full Text] [Related]
12. Cten mRNA expression was correlated with tumor progression in lung cancers. Sasaki H; Moriyama S; Mizuno K; Yukiue H; Konishi A; Yano M; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y Lung Cancer; 2003 May; 40(2):151-5. PubMed ID: 12711115 [TBL] [Abstract][Full Text] [Related]
13. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L; Turkson J; Karras JG; Jove R; Haura EB Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation. Wang X; Chen Z Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748 [TBL] [Abstract][Full Text] [Related]
15. CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells. Lu X; Gao J; Zhang Y; Zhao T; Cai H; Zhang T PLoS One; 2018; 13(7):e0198823. PubMed ID: 29985912 [TBL] [Abstract][Full Text] [Related]
16. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells. Ge X; Peng X; Li M; Ji F; Chen J; Zhang D Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182 [TBL] [Abstract][Full Text] [Related]
17. Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma. Chan LK; Chiu YT; Sze KM; Ng IO Oncotarget; 2015 Aug; 6(25):20964-76. PubMed ID: 26035355 [TBL] [Abstract][Full Text] [Related]
18. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer. Lo SH; Lo TB Cancer Res; 2002 Aug; 62(15):4217-21. PubMed ID: 12154022 [TBL] [Abstract][Full Text] [Related]
19. CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer. Li Y; Mizokami A; Izumi K; Narimoto K; Shima T; Zhang J; Dai J; Keller ET; Namiki M Prostate; 2010 Jan; 70(1):48-60. PubMed ID: 19725034 [TBL] [Abstract][Full Text] [Related]
20. ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion. Yang K; Wu WM; Chen YC; Lo SH; Liao YC PLoS One; 2016; 11(1):e0147542. PubMed ID: 26784942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]